Reference priceEUR €0.98Original source price: INR 89.50. Converted estimates are available by currency selection.
| Brand | Zeffix |
|---|---|
| Manufacturer | GlaxoSmithKline GmbH & Co.KG |
| Prescription required | Yes |
Zeffix 100mg Comprimidos,28 x 1(Lamivudine)
Lamivudine
Description
Zeffix 100mg Comprimidos,28 x 1(Lamivudine) is a medicine catalog record in the MediPriceHub database. Active ingredient: Lamivudine. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: GlaxoSmithKline GmbH & Co.KG. Therapeutic category: Medicine Library > Liver and Gallbladder Diseases > Hepatitis B Vaccine. Pack information: 100, 28. Origin country or market: Spain. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.Benefits
TRIUMEQ and TRIUMEQ PD are indicated for the treatment of HIV-1 infection in adults and in pediatric patients aged at least 3 months and weighing at least 6 kg. Limitations of Use: TRIUMEQ and TRIUMEQ PD alone are not recommended in patients with resistance‑associated integrase substitutions or clinically suspected integrase strand transfer inhibitor (INSTI) resistance because the dose of dolutegravir in TRIUMEQ and TRIUMEQ PD is insufficient in these subpopulations. See full prescribing information for TIVICAY (dolutegravir).How to Use
Use Lamivudine under the supervision of a qualified healthcare professional. Take it by mouth only according to the approved label and the dose prescribed by a qualified healthcare professional. Do not start, stop, change the dose, split or crush a dosage form, mix with other medicines, or repeat a course unless the approved product information or a clinician confirms that it is appropriate. Check the local prescribing information for age limits, dose adjustments, missed-dose instructions, storage after opening or reconstitution, and monitoring requirements.Specification
Active ingredient: Lamivudine. Pack size: 100, 28. Pack unit: box. Manufacturer: GlaxoSmithKline GmbH & Co.KG. Origin country: Spain. Source category: Medicine Library > Liver and Gallbladder Diseases > Hepatitis B Vaccine. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.Side Effects
Anti-infective medicines may cause nausea, diarrhea, abdominal discomfort, headache, rash, allergic reactions, liver enzyme changes, interactions with other medicines, or organism-specific resistance concerns. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, confusion, serious bleeding, signs of infection, or rapidly worsening symptoms. The approved local prescribing information is the controlling source for the complete adverse-reaction profile.Ces informations sont fournies à titre indicatif. Demandez conseil à un professionnel de santé avant d'utiliser un médicament.